Search Within

Shin Hyuk Seo

Formats
  1. Meeting Abstract (6)
  2. Journal Article (2)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (8)
  2. Center for Molecular Imaging and Biotechnology (CMIB) (8)
  3. GSK Faculty (8)
  4. Molecular Imaging and Therapy Service (8)
  5. Molecular Pharmacology and Chemistry Program Faculty (8)
  6. Neuroblastoma Service (8)

More Groups

People
  1. Darren Veach (8)
  2. Nai-Kong Cheung (8)
  3. Steven Larson (8)
  4. Hong Xu (7)
  5. Hong-Fen Guo (7)
  6. Sarah Cheal (7)

More People

Years
  1. 2024 (1)
  2. 2023 (1)
  3. 2022 (4)
  4. 2021 (2)
Publications
  1. Journal of Nuclear Medicine (3)
  2. Nuclear Medicine and Biology (3)
  3. Cancer Research (2)
Publishers
  1. Elsevier Science Inc. (3)
  2. Society of Nuclear Medicine (3)
  3. American Association for Cancer Research (2)

Results (8)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Theranostic GPA33-pretargeted radioimmunotherapy of human colorectal carcinoma with a bivalent (177)Lu-labeled radiohapten
    Journal Article

    Vaughn, B. A.; Lee, S. G.; Vargas, D. B.; Seo, S.; Rinne, S. S.; Xu, H.; Guo, H. F.; Le Roux, A. B.; Gajecki, L.; Krebs, S.; more...
    Journal of Nuclear Medicine (2024)

    Fulltext@MSK | Save
  • Efficacy of HER2-targeted intraperitoneal (225)Ac α-pretargeted radioimmunotherapy for small-volume ovarian peritoneal carcinomatosis
    Journal Article

    Chung, S. K.; Vargas, D. B.; Chandler, C. S.; Katugampola, S.; Veach, D. R.; McDevitt, M. R.; Seo, S. H.; Vaughn, B. A.; Rinne, S. S.; Punzalan, B.; more...
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • Self-assembling and disassembling (SADA) domain is critical to the binding, and anti-tumor efficacy of GD2-SADA
    Meeting Abstract

    Santich, B. H.; Kjellev, S. L.; Cheal, S.; Wang, L.; Gillberg, M.; Vadlamudi, M.; Ouattara, A. A.; Liebenberg, N.; Larsen, L. F.; Veach, D. R.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Establishment of efficacy of DOTA-based pretargeted radioimmunotherapy with a bivalent radiohapten for enhanced therapeutic indices
    Meeting Abstract

    Vaughn, B.; Veach, D.; Vargas, D. B.; Seo, S.; Punzalan, B.; Zanzonico, P.; Xu, H.; Guo, H. F.; Yang, G.; Ouerfelli, O.; more...
    Journal of Nuclear Medicine (2022)

    Fulltext@MSK | Save
  • Synthesis and evaluation of a bivalent radiohapten for DOTA-based pretargeted radioimmunotherapy
    Meeting Abstract

    Veach, D.; Vaughn, B.; Vargas, D. B.; Seo, S.; Punzalan, B.; Xu, H.; Guo, H. F.; Krebs, S.; Yang, G.; Ouerfelli, O.; more...
    Nuclear Medicine and Biology (2022)

    Fulltext@MSK | Save
  • (111)In/(225)Ac theranostic pretargeting of nodular colorectal peritoneal carcinomatosis: Preclinical SPECT and autoradiography studies
    Meeting Abstract

    Chung, S.; Chandler, C.; Veach, D.; McDevitt, M.; Zanzonico, P.; Seo, S.; Punzalan, B.; Burnes Vargas, D.; Xu, H.; Guo, H. F.; more...
    Nuclear Medicine and Biology (2022)

    Fulltext@MSK | Save
  • Self-assembling and disassembling bispecific antibody platform for pretargeted radioimmunotherapy against GPA33 in a xenograft model of colorectal peritoneal carcinomatosis
    Meeting Abstract

    Chung, S.; Wang, M.; Veach, D.; Cheal, S.; Burnes Vargas, D.; Seo, S. H.; Punzalan, B.; Santich, B.; Guo, H. F.; Xu, H.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Optimized pretargeting of [(89)Zr]Zr-DO3A-proteus radiohapten in rodent models of human colorectal cancer
    Meeting Abstract

    Le Roux, A.; Cheal, S.; Veach, D.; Ouerfelli, O.; Yang, G.; Longo, V.; Guo, H. F.; Seo, S.; Burnes Vargas, D.; Xu, H.; more...
    Nuclear Medicine and Biology (2021)

    Fulltext@MSK | Save